1. Home
  2. PC vs EQ Comparison

PC vs EQ Comparison

Compare PC & EQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PC
  • EQ
  • Stock Information
  • Founded
  • PC 2012
  • EQ 2017
  • Country
  • PC Singapore
  • EQ United States
  • Employees
  • PC N/A
  • EQ N/A
  • Industry
  • PC Restaurants
  • EQ Biotechnology: Pharmaceutical Preparations
  • Sector
  • PC Consumer Discretionary
  • EQ Health Care
  • Exchange
  • PC Nasdaq
  • EQ Nasdaq
  • Market Cap
  • PC 11.7M
  • EQ 13.1M
  • IPO Year
  • PC 2024
  • EQ 2018
  • Fundamental
  • Price
  • PC $7.19
  • EQ $0.89
  • Analyst Decision
  • PC
  • EQ Buy
  • Analyst Count
  • PC 0
  • EQ 3
  • Target Price
  • PC N/A
  • EQ $3.00
  • AVG Volume (30 Days)
  • PC 164.4K
  • EQ 20.3M
  • Earning Date
  • PC 02-15-2025
  • EQ 08-19-2025
  • Dividend Yield
  • PC N/A
  • EQ N/A
  • EPS Growth
  • PC N/A
  • EQ N/A
  • EPS
  • PC N/A
  • EQ N/A
  • Revenue
  • PC $3,345,964.00
  • EQ $30,406,000.00
  • Revenue This Year
  • PC N/A
  • EQ N/A
  • Revenue Next Year
  • PC N/A
  • EQ N/A
  • P/E Ratio
  • PC N/A
  • EQ N/A
  • Revenue Growth
  • PC N/A
  • EQ N/A
  • 52 Week Low
  • PC $5.11
  • EQ $0.27
  • 52 Week High
  • PC $51.57
  • EQ $1.50
  • Technical
  • Relative Strength Index (RSI)
  • PC N/A
  • EQ 70.41
  • Support Level
  • PC N/A
  • EQ $0.46
  • Resistance Level
  • PC N/A
  • EQ $0.80
  • Average True Range (ATR)
  • PC 0.00
  • EQ 0.18
  • MACD
  • PC 0.00
  • EQ 0.03
  • Stochastic Oscillator
  • PC 0.00
  • EQ 52.58

About PC Premium Catering (Holdings) Limited Ordinary Shares

Premium Catering (Holdings) Ltd is a company that conducts its operations through its subsidiary is mainly engaged in food catering for functions, events, and workers in Singapore. Are specialized in Indian, Bangladesh, and Chinese cuisine and all its food products are Halal food which is permissible for consumption by Muslims to consume. Are an ACRA registered company and licensed by SFA to operate and process food business. Serve highquality value-packed food, company deliver's a reliable and dependable service to meet customer's daily meal requirements. The Company recognizes revenue from sales of budgeted prepared meals.

About EQ Equillium Inc.

Equillium Inc is a clinical-stage biotechnology company engaged in developing novel therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need. The company intends to commercialize its product candidates either independently or through partnerships, or otherwise monetize its pipeline through strategic transactions. Itolizumab (EQ001), a clinical-stage product candidate, is an anti-CD6 immune-modifying monoclonal antibody, or mAb, that selectively targets the CD6-ALCAM signaling pathway to downregulate pathogenic T effector cells while preserving T regulatory cells critical for maintaining a balanced immune response. The company's other clinical-stage and pre-clinical-stage candidates include EQ101 and EQ302.

Share on Social Networks: